Indy Star interviewed Thomas F. Imperiale, M.D., about his study published in the New England Journal of Medicine. This next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers and has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.
-
Research
- Experts
In The News
View AllMSN features Dr. Brian Dixon
Brian Dixon, PhD, MPA, was featured on MSN about a...
Influence
View AllIs the Multitarget Stool DNA Test Just a Better “FIT” for Colorectal Cancer Screening?
Published in the journal JAMA Internal Medicine. Here is a...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
March 19, 2024
Indy Star interviewed Dr. Thomas F. Imperiale
"*" indicates required fields